The summary below is from the full report titled “Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes. A Randomized Trial.” It is in the 18 October 2005 issue of Annals of Internal Medicine (volume 143, pages 559-569). The authors are R.J. Heine, L.F. Van Gaal, D. Johns, M.J. Mihm, M.H. Widel, and R.G. Brodows, for the GWAA Study Group.
Exenatide or Insulin Glargine for Suboptimally Controlled Diabetes?. Ann Intern Med. 2005;143:I–30. doi: https://doi.org/10.7326/0003-4819-143-8-200510180-00002
Download citation file:
Published: Ann Intern Med. 2005;143(8):I-30.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use